Dupuytren's disease risk factors

J Hand Surg Br. 2004 Oct;29(5):423-6. doi: 10.1016/j.jhsb.2004.06.006.

Abstract

Dupuytren's is a common problem, but little is known about its aetiology. We have undertaken a large case-control study to assess and quantify the relative contributions of diabetes and epilepsy as risk factors for Dupuytren's in the community. Cases were patients with a diagnosis of Dupuytren's disease and, for each, two controls were individually matched by age, sex, and general practice. Our dataset included 821 cases and 1,642 controls. Five hundred and eighty-eight (72%) of the cases were men. The mean age at diagnosis was 62 (range 24-97) years. Diabetes was a significant risk factor for Dupuytren's disease (OR=1.75) and there was an increased risk for medicinally treated diabetes (metformin--OR=3.56; sulphonylureas--OR=1.75) and particularly insulin controlled (OR=4.38) rather than diet-controlled diabetes. Epilepsy (OR=1.12) and anti-epileptic medications were not associated with Dupuytren's disease. Ascertainment bias in previous studies may explain the reported association with epilepsy.

MeSH terms

  • Adult
  • Age Distribution
  • Aged
  • Aged, 80 and over
  • Case-Control Studies
  • Databases as Topic
  • Diabetes Mellitus / drug therapy
  • Diabetes Mellitus / epidemiology
  • Dupuytren Contracture / diagnosis
  • Dupuytren Contracture / epidemiology*
  • Dupuytren Contracture / surgery
  • Female
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Insulin / therapeutic use
  • Male
  • Metformin / therapeutic use
  • Middle Aged
  • Office Visits / statistics & numerical data
  • Risk Factors
  • Sulfonylurea Compounds / therapeutic use
  • United Kingdom / epidemiology

Substances

  • Hypoglycemic Agents
  • Insulin
  • Sulfonylurea Compounds
  • Metformin